聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 19 分钟 36 秒 前

Volcano receives CE mark for iFR Scout Pullback software to help diagnose serial lesions and diffuse coronary disease

周四, 03/12/2015 - 15:52
AMSTERDAM and SAN DIEGO , March 12, 2015 (Healthcare Sales & Marketing Network) -- Royal Philips (NYSE: PHG; AEX: PHIA), today announced that Volcano, a Philips business, has received CE Mark for the iFR Scout pullback software, a functional extension of ...
Devices, Interventional Cardiology, Regulatory
Royal Philips, Volcano, iFR Scout, Fractional Flow Reserve

Varian Medical Systems Selected to Equip Two National Proton Therapy Centers in England

周三, 03/11/2015 - 22:18
CRAWLEY, England, March 11, 2015 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR) today announced that it has been selected to equip and service two new national proton therapy centers in England with the Varian ProBeam® proto...
Devices, Oncology
Varian Medical Systems, proton therapy, ProBeam, radiotherapy

Cardiac Dimensions(R) Completes $43M Equity Financing

周三, 03/11/2015 - 22:10
$15.2 Million Infusion from International Investors Rounds Out Financing; Funds Will Support Landmark Trial, Expand Commercial Operations KIRKLAND, Wash., March 11, 2015 -- (Healthcare Sales & Marketing Network) -- Cardiac Dimensions® today announc...
Devices, Cardiology, Venture Capital
Cardiac Dimensions, percutaneous mitral repair, CARILLON, mitral regurgitation

Pathway Genomics Appoints Former Cedars-Sinai Chair of Medicine Glenn D. Braunstein, M.D., as Chief Medical Officer

周三, 03/11/2015 - 22:04
SAN DIEGO--(Healthcare Sales & Marketing Network)--Pathway Genomics Corporation, a forward-thinking big data healthcare company and global precision medicine clinical laboratory, has announced that endocrinologist Dr. Glenn D. Braunstein is the company’s n...
Diagnostics, Personnel
Pathway Genomics

Mylan Launches Generic Antabuse(R) Tablets

周三, 03/11/2015 - 14:12
POTTERS BAR, England and PITTSBURGH, March 11, 2015 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (MYL) and Mylan Inc. today announced the U.S. launch of Disulfiram Tablets USP, 250 mg and 500 mg, which is the generic version of Odyssey Pharmace...
Biopharmaceuticals, Generics, FDA
Mylan, Odyssey Pharmaceutical, Disulfiram, Antabuse

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong